Watsana Phongsaengluek - Com7 PCL Executive Director, Deputy Chief Financial Officer
| COM7 Stock | THB 27.00 0.75 2.86% |
Director
Ms. Watsana Phongsaengluek serves as Executive Director and Deputy Chief Financial Officer of Com7 PCL since 2014. She holds a MBA degree from University of Wales and a Bachelor of Business Administration degree in Accounting from Assumption University. since 2014.
| Age | 45 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 66 2 017 7777 |
| Web | https://www.comseven.com |
Com7 PCL Management Efficiency
The company has return on total asset (ROA) of 0.1507 % which means that it generated a profit of $0.1507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5615 %, meaning that it generated $0.5615 on every $100 dollars invested by stockholders. Com7 PCL's management efficiency ratios could be used to measure how well Com7 PCL manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sripop Sarasas | Bangkok Dusit Medical | 66 | |
| Phatcharavat Wongsuwan | CP ALL Public | 70 | |
| Santasiri Sornmani | Bangkok Dusit Medical | 84 | |
| Naporn Sunthornchitcharoen | Home Product Center | 64 | |
| Prasert Jarupanich | CP ALL Public | 70 | |
| Chavalit Sethameteekul | Bangkok Dusit Medical | 71 | |
| Pradit Theekakul | Bangkok Dusit Medical | 60 | |
| Adirek Sripratak | CP ALL Public | 73 | |
| Chairat Panthuraamphorn | Bangkok Dusit Medical | 64 | |
| Raweporn Kuhirun | Gulf Energy Development | 75 | |
| Sommai Phasee | Gulf Energy Development | 74 | |
| Santi Boonprakub | Gulf Energy Development | 66 | |
| Weerawong Chittmittrapap | Bangkok Dusit Medical | 62 | |
| Yupapin Wangviwat | Gulf Energy Development | 53 | |
| Chotikul Sookpiromkasem | Gulf Energy Development | 43 | |
| Pridi Boonyoung | CP ALL Public | 79 | |
| Arsa Sarasin | Bangkok Dusit Medical | 82 | |
| Prasobsook Boondech | CP ALL Public | 72 | |
| Emmanuel Rajakarier | Minor International Public | 58 | |
| Umroong Sanphasitvong | CP ALL Public | 66 | |
| Thongchai Jiraalongkorn | Bangkok Dusit Medical | 59 | |
Management Performance
| Return On Equity | 0.56 | |||
| Return On Asset | 0.15 |
Com7 PCL Leadership Team
Elected by the shareholders, the Com7 PCL's board of directors comprises two types of representatives: Com7 PCL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Com7. The board's role is to monitor Com7 PCL's management team and ensure that shareholders' interests are well served. Com7 PCL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Com7 PCL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Khatchaphon Chunlachart, Independent Director | ||
| Wassana Pongsangluk, CFO Director | ||
| Phakphum Satarat, COO CHRO | ||
| Siripong Sombutsiri, Chairman of the Board, Independent Director | ||
| Sura Khanitthawikun, Director, Chief Executive Officer, Vice Chairman of the Board | ||
| Khongsak Bannasathitkun, Director, Executive Director, Deputy Chief Executive Officer | ||
| Sasipa Sawangsawai, Company Sec | ||
| Sasipha Sawangsawai, Company Secretary | ||
| Kaspol Chulajata, Director | ||
| Natthanan Keeratikornyossanan, COO Director | ||
| Natthanan Kiratikornyotsanan, Executive Director, Deputy Chief Operating Officer | ||
| Wariphorn Udomkhunnatham, Independent Director | ||
| Nattanan Kiratikornyossanan, Chief Bus | ||
| Watsana Phongsaengluek, Executive Director, Deputy Chief Financial Officer | ||
| Aree Prichanukun, Director, Executive Director, Deputy Chief Executive Officer of Management | ||
| Kongsak Bannasathitgul, Chief People Officer | ||
| Aree Preechanukul, Chief Admin. Officer | ||
| Somboon Aueatchasai, Independent Director | ||
| Kritchawat Worawanit, Director, Executive Director, Assistant Chief Executive Officer of Laws | ||
| Narong Sriwannawit, COO Director | ||
| Kritchawat Voravanich, Assistant Director | ||
| Sura Khanittaweekul, Vice CEO |
Com7 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Com7 PCL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.56 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 84.27 B | |||
| Shares Outstanding | 2.38 B | |||
| Shares Owned By Insiders | 57.94 % | |||
| Shares Owned By Institutions | 6.50 % | |||
| Price To Earning | 49.15 X | |||
| Price To Book | 12.22 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Com7 Stock
Com7 PCL financial ratios help investors to determine whether Com7 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Com7 with respect to the benefits of owning Com7 PCL security.